Semarion

Startup

Semarion is a spin-out company from Cambridge University with a mission to accelerate the pace of drug discovery. We are revolutionising adherent cell screening to produce better drug data, faster. Our proprietary SemaCyte® microcarrier platform leverages novel materials physics to introduce flexibility, miniaturisation, and multiplexing into existing drug discovery workflows. Our assaying microcarriers function as magnetically steerable, ultra-miniaturized wells which carry small colonies of adherent cells into suspension. These materials are compatible with typical research tools and equipment, where they accelerate workflows and enable novel research methodologies.


website